Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders

Kocaman, Gülşen; Kahraman, Nese; Gurkan Koseoglu, Banu; Bilgic, Başar; Matur, Zeliha; Ertas, Mustafa; Gulsen, Yesim; Baykan Baykal, Betul

doi:10.5152/npa.2017.19257

Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders

Copy For Citation

Kocaman G., Kahraman N., Gurkan Koseoglu B., Bilgic B., Matur Z., Ertas M., ...More

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.55, no.4, pp.330-336, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 55 Issue: 4
Publication Date: 2018
Doi Number: 10.5152/npa.2017.19257
Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.330-336
Istanbul University Affiliated: Yes

Abstract

Introduction: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. In this study, it is aimed to compare the efficacy of onabotulinumtoxinA treatment in CM patients with and without TMD.